Pathology Surgical Articles & Analysis
1 news found
"We are extremely excited by these data linking INT41 results to specific molecular events in Huntington's pathology. INT41 provides a surgical approach to inactivate the event for which a growing body of evidence indicates occurs prior to symptoms and may be the driver of disease progression" said Lee Henderson, Ph.D., the CEO of Vybion and a coauthor on the ...
ByVybion